Ampliphi Biosciences Corp (NYSEAMERICAN:APHB)’s share price gapped up prior to trading on Friday . The stock had previously closed at $0.84, but opened at $1.12. Ampliphi Biosciences shares last traded at $1.42, with a volume of 4634500 shares changing hands.
Separately, HC Wainwright set a $5.00 price target on shares of Ampliphi Biosciences and gave the company a “buy” rating in a research note on Wednesday, November 15th.
The company has a market cap of $13.49, a PE ratio of -0.14 and a beta of 2.93.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation is a biotechnology company. The Company is focused on the discovery, development and commercialization of phage therapeutics. The Company is engaged in identifying, characterizing and developing naturally occurring bacteriophages with its collaboration partners in bacteriophage biology, synthetic biology and manufacturing, to develop second-generation bacteriophage products.
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.